Trade Mark Journal No.2026/034 21 August 2026

UK00004427188 6 August 2026 (42,44)

ExoOrgan

International priority date claimed: 6 August 2026 (European Union Intellectual Property Office (EUIPO)) (019405897)

Class 42: Medical and pharmacological research services; Scientific research for medical purposes; Medical research; Medical research services; Biological research, clinical research and medical research; Medical research laboratory services; Medical research in the field of pathology; Medical research in the field of oncology; Analysis of human serum for medical research; Analysis of human tissues for medical research; Medical research in the field of rare diseases; Providing medical research information in the field of genetics; Providing scientific research information in the field of genetics; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of medical preparations; Research and development in the field of diagnostic preparations; Research and development services in the field of immunology; Scientific investigations for medical purposes; Scientific research for medical purposes in the area of cancerous diseases; Scientific research; Research and development of pharmaceutical preparations for treating malignant tumours; Provision of information and data relating to medical and veterinary research and development; Providing information about the results of clinical trials for pharmaceutical products.
Class 44: Health care; Remote monitoring of medical data for medical diagnosis and treatment; Health counselling; Public health counseling; Medical counselling; Medical testing for diagnostic and treatment purposes; Pathological testing for diagnostic or treatment purposes; Medical examinations; Medical screening; Health screening; Medical treatment using cultured cells; Pathological examination for medical diagnosis and treatment; Pathological testing for diagnostic and treatment purposes; Therapy services; Human tissue bank services; Cultured cell bank services for medical transplantation; Hospital services; Medical clinic services.

Organogenesis Labs Inc

Representative: Dr Stoyan Radkov